Stago
2 known investors
Find your way into Stago
Sign up to see every warm intro you have to Stago
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Stago team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Stago develops and manufactures hemostasis testing systems, analyzers, and reagents for clinical and laboratory diagnostics. Its products support blood coagulation and platelet function testing for laboratories, customers, and distributors.
Investors · 2
ARCHIMED Japanlisted by ARCHIMED JapanLyon · $10.8M – $1.1B
How we know: ARCHIMED Japan's portfolio page · Not right? Tell us
La CaissereportedMontréal
How we know: funding news · Not right? Tell us
Frequently asked questions
- What does Stago do?
- Stago develops and manufactures hemostasis testing systems, analyzers, and reagents for clinical and laboratory diagnostics. Its products support blood coagulation and platelet function testing for laboratories, customers, and distributors.
- Who are Stago's investors?
- Stago's investors include ARCHIMED Japan, La Caisse.